Summary

Evaluating Therapeutic and Chemical Toxicity Using Organ-Cultured Porcine Corneas and Epithelial Wound Healing

Published: January 10, 2025
doi:

Summary

Porcine corneal ex vivo organ culture and epithelial wound healing provide an economical, ethical, reproducible, and quantitative means for testing the ocular toxicity of chemicals. They also aid in elucidating mechanisms underlying the regulation of epithelialization and tissue repair, and in evaluating therapeutics for treating diabetic keratopathy and delayed wound healing.

Abstract

Due to its anatomical and physiological similarities to the human eye, the porcine eye serves as a robust model for biomedical research and ocular toxicity assessment. An air/liquid corneal culture system using porcine eyes was developed, and ex vivo epithelial wound healing was utilized as a critical parameter for these studies. Fresh pig corneas were processed for organ culture, with or without epithelial wounding. The corneas were cultured in a humidified 5% CO2 incubator at 37 °C in MEM, with or without testing agents. Corneal permeability and wound healing rates were measured, and epithelial cells and/or whole corneas can be processed for immunohistochemistry, western blotting, and qPCR for molecular and cellular analyses. This study describes a detailed protocol and presents two studies using this ex vivo system. The data show that porcine corneal organ culture, combined with epithelial wound healing, is a suitable ex vivo model for chemical toxicity testing, studying diabetic keratopathy, and identifying potential therapies.

Introduction

While cell models possess limited clonal populations and fail to reproduce an organism's in vivo architecture, organ culture or explant offers insights into organ function, development, disease mechanisms, and potential therapies while providing ethical and physiological advantages over other experimental models1,2. In addition to reducing the number of animals needed, culturing explants control and sensibly manipulate the surrounding conditions, which is ideal for a detailed exploration of factors controlling cell proliferation, migration, wound response, and cellular differentiation in an organ culture setting2,3. Among different tissues/organs, corneal explants, including that of humans4,5,6, have been used broadly for ocular toxicity, irritation assessments7,8, to study molecularly mechanisms underlying stem cell function9 and wound healing10,11, and to Primary open-angle glaucoma12.

Porcine corneas share several structural and physiological similarities with human corneas, making them an excellent model for studying human corneal biology and diseases. Structurally, both have Bowman's layer, 5-7 layers of epithelial cells, and similar curvature and diameter. Physiologically, they are highly transparent, have similar tear film composition and corneal hydration, exhibit comparable patterns and functions of corneal innervation, and follow similar wound healing processes, making them an excellent model for studying human corneal biology and diseases13,14. While human and porcine corneas have slight differences in collagen fibril arrangement and water content, their immune signaling and responses are not identical. These differences pose challenges for xenotransplantation15. Hence, species-specific differences must be considered while interpreting experimental data.

Compared to human corneas, porcine eyes are readily available as byproducts of the meat industry, making them cost-effective and easily accessible for research14. Using porcine corneas helps reduce the need for human donor corneas and minimizes the ethical concerns associated with animal testing. Moreover, the availability of many porcine corneas at one time allows for consistent and reproducible experiments, which is crucial for reliable research outcomes.

A porcine corneal organ culture system was initially used to replace animal tests of cosmetic chemicals and ocular drugs7. This system has been used to study corneal epithelial wound healing and to identify several important signal pathways such as HB-EGF ectodomain shedding, lipid mediator lysophosphatidic acid stimulation, and EGFR activation for corneal wound healing16,17. Using high glucose as a pathologic factor, an ex vivo model of hyperglycemia was established with delayed epithelial wound healing to mimic human diabetic keratopathy. Using this model, the balance expressions of IL-1β versus IL-1Ra18 and TGFβ3 versus TGFβ119 were shown to be important factors for proper wound healing in the corneas, and manipulation of these balances may be used to treat diabetic keratopathy. Hence, porcine organ culture represents a relevant, economical, and manipulating experiment system with various applications in chemical toxicity tests, biomedical research, drug discovery, and assessing tissue damage and repair in response to ocular exposure to chemical weapons.

In this article, a detailed protocol of porcine corneal organ culture is described, and its applications for assessing the potential effects of ocular NSAID (NS) eye drops on corneal health and for determining signaling pathways and biological processes involved in the pathogenesis of diabetic keratopathy are illustrated.

Protocol

Since fresh pig corneas are a byproduct of the food industry, the Institutional Animal Care and Use Committee did not need to approve their use for research. Unlike human corneas used in research, there are no biohazard concerns, and unused parts of pig eyes can be disposed of as regular garbage. The reagents and equipment used for this study are listed in the Table of Materials.

1. Preparation for organ culture

  1. Add penicillin-streptomycin to the Minimum essential medium (MEM) as supplements before use.
  2. Prepare high-glucose culture media by adding 3.6 g of D-glucose to 1 L of supplemented MEM, which contains 5 mM glucose (equal to 90 mg/dL), to reach a 25 mM (equal to 450 mg/dL) final glucose concentration, mimicking hyperglycemia in diabetic patients.
  3. Prepare 1% agarose in supplemented MEM with 5 mM or 25 mM glucose by adding 0.2 g agarose to 20 mL of MEM and heating it in a microwave until the agarose dissolves.
  4. Transfer the agarose-containing solution into a water bath maintained at 48 °C.
  5. Before the experiment, autoclave all experimental reagents, such as distilled water, PBS, and surgical equipment: hemostat, forceps, scalpel handle, scissors, and trephine, as well as beakers, paper towels, lint-free wipes, gloves, and pipette tips. Soak the silicon mold, razor blade, and blade holder in 70% alcohol for 30 min and wash with sterile PBS three times.

2. Porcine eyeball preparation for corneal culture

  1. Obtain porcine eyeballs from a local abattoir and transport them to the laboratory on ice in a moist chamber.
    NOTE: Bovine eyes can also be used in a similar fashion. However, bovine eyes and corneas differ from human eyes/corneas more remarkably. For example, human and porcine corneas have 5-7 layers of epithelial cells, while bovine corneas have about 20 layers13,14. Moreover, bovine eyes are more likely to be contaminated during corneal organ culture; hence, more bovine eyes are needed for statistical analysis.
  2. Place the porcine eyes in a 1 L beaker containing sterilized PBS.
    NOTE: The porcine eyeballs are collected within 1 h after slaughter and transported to the lab in about 2 h. Overall, the eyes were used within 4 h (step 2.3).
  3. Hold an eyeball with tweezers and remove the extraocular tissues with a scissor in a sterile Petri plate.
  4. Rinse the eyeballs with distilled water once and PBS twice.
  5. Rinse the eye bulbs with a PovidoneIodine antiseptic solution for 10 s, followed by sterilized PBS three times washing.
  6. Incubate the eyeballs in PBS containing 20 µg/mL gentamicin for 30 min and rinse them twice with PBS.

3. Epithelium wounding

  1. Hold an eyeball with sterilized lint-free wipes and mark the center of the corneas with a 6 mm trephine.
  2. Gently scrape epithelial cells within the trephine-marked circle with a small scalpel or corner-blunted soft razor blade, remove all cell debris but leave the basement membrane intact, and clean the wound area with cotton swabs.
    NOTE: The scalpel with collected epithelial cells can be transferred to a microcentrifuge tube placed on ice. The cells can be lysed immediately or stored in a -20 °C freezer to serve as the controls..

4. Corneal organ culture and ex vivo hyperglycemia modeling

  1. Dissect the eyeball by cutting along corneal-scleral rims with a scalpel and scissors and rinse the corneas in a sterilized 1000 mL beaker containing PBS (pH 7.4).
  2. Place the excised corneas upside down into a sterile mold made from non-toxic liquid mold-making silicone.
    NOTE: Pour the non-toxic silicone mold-making liquid into the holes of a 50 mL tissue culture/test tube rack, using the bottom of the 30 mL ultracentrifuge tube to make a half-round mold.
  3. Fill the endothelial corneal cavity with MEM containing 1% agarose maintained at 48 °C and allow the mixture to gel at the room temperature..
  4. Invert and transfer the corneas to a 35 mm dish, and add 2 mL of MEM with or without testing agent(s) dropwise to the surface of the central cornea to cover the limbal conjunctiva region, leaving the epithelium exposed to the air (Figure 1).
  5. Place the culture dishes in a humidified 5% CO2 incubator at 37 °C and replace the media with fresh MEM media with or without a testing agent(s) daily for 2 days.
  6. Establish an ex vivo hyperglycemia model by adding L-glucose to MEM to reach a total of 25 mM glucose, which is used for 1% agarose gel preparation and as culture media.

5. Corneal function assessment

  1. Determine the epithelial wound healing rate by staining the wounded corneas with Richardson's staining20 to mark the remaining wound area and photograph it (Figure 2 and Figure 3). Quantify the wound size with Image-J or Photoshop software (histogram).
  2. Process the corneas for histology, histochemistry, and immunohistochemistry analyses (Figure 2 and Figure 3) by embedding them in the OCT and cryostat sectioning. Fix the sections with ice-cold acetone, stain with H&E staining, or block with 1% BSA for 1 h for TUNEL staining or immunohistochemistry to detect proteins and signaling molecules (such as phosphorylated Erk and ATK).
    NOTE: Most commercially available antibodies were not tested for porcine antigens. However, if an antibody recognizes both human and mouse antigens, it can mostly be used to detect the corresponding porcine antigen Western blotting and immunohistochemistry.
  3. Wash the stained corneas with PBS and use the same-sized trephine to mark the original wound and scrap epithelial cells within the marker circles.
    1. Collect epithelial cells with a small scalpel, immerse the scalpel with collected cells a centrifuge tube precooled on ice.
    2. Store the collected cells in -80 °C deep freezer or extract them immediately and perform lysis for Western blotting and/or ELISA or in RNA extraction buffer for PCR (if required)10,16,21.

Representative Results

Cataract surgery is one of the most frequently performed procedures globally, and eye drops play a crucial role in post-surgery care. Applying eye drops after cataract surgery helps prevent complications such as eye infections, inflammation, and macular edema. NSAID (NS) eye drops, including ketorolac, bromfenac, and nepafenac, have commonly been used to treat pain and swelling of the eye before, during, and after cataract surgery. The long-term use of these eye drops that contain various amounts of preservatives, such as benzalkonium chloride, may have adverse effects on the health of the corneas22.

Using pig corneal organ culture, the effects of these NS eye drops on the rate of epithelial wound healing were assessed (Figure 2). Pig corneas were processed for organ culture as described in the protocol section, and culture in MEM media with or without NS eye drops applied as described in Figure 1. Corneas cultured in MEM medium alone as the control (without BAK) had the mean (SD) of remaining wound areas at 48 hours presented as 565 ± 1263 pixels while treated corneas had 47,322 ± 13,736 pixels for Nepafenac 0.1% (0.05% BAK), 29,093 ± 14,295 pixels for bromfenac 0.09% (0.005% BAK), and 29,093 ± 14,295 pixels for ketorolac 0.45% (0% BAK), respectively.

The remaining wound areas were notably smaller in corneas treated with ketorolac 0.45% than those treated with nepafenac 0.1% (P < 0.01) or bromfenac 0.09%. Additionally, corneas treated with nepafenac 0.1% had a remarkably larger mean remaining wound area compared to those treated with bromfenac 0.09% (P < 0.01). There were no significant differences between the mean of the control and ketorolac 0.45% treated corneas. The mean of the remaining wound area of the corneas appeared to be related to the concentration of BAK. Hence, reducing BAK concentrations or total abandonment as a preservative has been the trend for developing new or improving existing eye drops and medications.

Using cultured porcine corneas as an ex vivo model to study epithelial wound healing, it was found that epithelial wound closure was highly impaired in corneas cultured under high glucose conditions (25 mM glucose) compared to those cultured in normal glucose (5 mM glucose) or high mannitol (5 mM of glucose containing 20 mM of D-mannitol, used as an osmotic control)10. For instance, the ability of LL-37, a peptide secreted by epithelial and immune cells from the gene cathelicidin, to rescue wound healing delayed by high glucose was tested in porcine corneas cultured under normal or high glucose conditions. Corneas cultured in normal glucose completely healed a 4 mm wound within 48 h, while those in high glucose conditions exhibited significantly slower wound closure. LL-37 at concentrations of 0.2 µg/mL and 0.5 µg/mL significantly accelerated wound healing that was delayed by high glucose. Using this model, the involvement of EGFR signaling10, IL-1Ra18, and TGFβ isoforms19 in promoting corneal epithelial wound healing was reported in pig corneas cultured in 25 mM glucose. These results were confirmed in mouse models of type 1 and/or type 2 diabetes19,23,24. Hence, studies combining ex vivo models of hyperglycemia and in vivo, mouse models of diabetes not only greatly reduce the number of live animals needed but also allow the large-scale screening of agents, alone or in combination, for their ability to improve diabetic wound healing, which is usually impaired in diabetic patients with an enormous amount of emotional, social, and economic burdens to the patient's family and the society.

Figure 1
Figure 1: Diagram of the corneal organ culture model for chemical toxicity tests. The convex shape of the cornea was maintained by an agarose/collagen gel in MEM, which supports the overlying endothelial cells. To cover the limbal region, drop by drop the culture medium was added to the center of the cornea. The dissolved test chemicals in the culture medium were also applied drop by drop to ensure thorough wetting of all surfaces. Please click here to view a larger version of this figure.

Figure 2
Figure 2: Corneal epithelial wound healing in cultured porcine corneas treated with NS eye drops. (A) Representative images of epithelial wound closure induced by NS eye drops in cultured porcine corneas. A 4 mm diameter epithelial wound was created and allowed to heal for 48 h in MEM (Control); 2-3 eye drops were applied to the cultured corneas every other hour during the daytime. Richardson staining solution was used to stain the wounded corneas to reveal the initial wound and the remaining wound areas in both the control (MEM) and NS-treated corneas. (B) Evaluation of wound healing in cultured porcine corneas treated with different NS. The extent of wound coverage (0% for no migration and 100% for complete coverage of the wound bed) was determined as described in the protocol section. Data are presented as mean ± SD of at least five corneas. Please click here to view a larger version of this figure.

Figure 3
Figure 3: LL-37 reduces high glucose-mediated delay in epithelial wound healing in porcine corneal organ culture. The epithelial wound of 5 mm diameter was made (A, original wound) in the center of porcine corneas and allowed to heal for 48 h in MEM containing NG (B; 5 mM d-glucose), or high glucose (C; 25 mM d-glucose) in the presence of 0.2 µg/mL (D) or 0.5 µg/mL (E) LL-37. Organ-cultured corneas were stained with Richardson staining solution to show the remaining wounds. Micrographs represent 1 of 3 samples performed each time. The bar graph represents the statistical analysis of the extent of healing. Values are expressed as mean ± SEM. *P < 0.05 and **P < 0.01 (Student's t-test) compared with HG. Results are representative of five independent experiments. This figure is adapted from Yin et al.25. Please click here to view a larger version of this figure.

Discussion

Cultured bovine and mostly porcine corneas have been used to assess the toxicities of cosmetic chemicals, glaucoma medications, and nonsteroidal anti-inflammatory drugs21,26. Pig corneas have also been used as an ex vivo model of human diabetic keratopathy. Unlike rabbit eyes, the pig eye resembles the human eye anatomically, physiologically, and biomechanically27, hence, being used for xenotransplantation into human15, including the cornea, liver, heart, and kidney. As such, the data generated using pig corneas should be more relevant to human exposure. Moreover, pig eyes are fresh, inexpensive, resistant to microbial contamination or infection during organ culture, and provide a relatively large amount of biological materials for molecular and cellular biology analyses. Hence, the pig corneal organ culture is an excellent ex vivo model with a broad application in biomedical research and in chemical toxicity determination.

Preventing the cultured corneas from microbial contamination is critical to this protocol’s success. In addition to thoroughly washing, treatment with a Povidone-iodine antiseptic solution and incubation with gentamicin for 30 min are important steps to minimize microbial contamination.

Although the organ culture maintains the structural integrity of tissues, the immune and neuronal elements are lacking. This is the major limitation of ex vivo studies. In many cases, organ culture or explant can be used as a complement to animal study. However, cosmetics chemicals must evaluate the ocular irritancy for their safe handling and use before releasing into the market28,29. The Draize rabbit eye irritation test, developed in 1944, has long been considered a gold standard for assessing eye irritation. However, it has faced criticism for animal welfare concerns due to its invasive and distressing procedures30. Animal testing has been banned. There is a great need for alternatives to animal testing for safety and efficacy testing of cosmetic products and cosmetic ingredients. Combining corneal organ culture with measurements of corneal epithelial permeability after chemical exposure holds promise as a mechanistically based alternative to in vivo animal testing30. Hence, using this ex vivo system may fulfill the goal of the 3Rs, particularly for testing cosmetics and newly produced chemicals for ocular toxicity and irritation8.

This ex vivo pig organ culture system was also used to compare the potential adverse effects of topical NS and demonstrated that removal of BAK in ketorolac 0.45% ketorolac 0.45% had statistically less impact on corneal re-epithelialization than prior ketorolac formulations (0.4% and 0.5%)31, bromfenac 0.09%, and nepafenac 0.01% (Figure 2). Several formulations developed by a company to increase the permeability of an IOP-lowering drug were also assessed for corneal toxicity, allowing ruling out certain formulations without further testing in animals and/or patients.

The studies using ex vivo models featuring high versus normal glucose cultures provide data complementary to mouse models of diabetic keratopathy and delayed wound healing (Figure 3). Using this combined approach, HB-EGF ectodomain shedding and EGFR activation10,16, exogenous lysophosphatidic acid17, and TGFβ3, but not β119,32 hasten delayed epithelial wound healing in diabetic corneas were demonstrated and, therefore, might be used to treat diabetic keratopathy. In addition, ex vivo organ culture can also be used to determine the dosage and time course of a tested reagent, providing experimental bases for in vivo study with fewer animals to be used. Hence, high glucose in organ-cultured pig corneas may be used for studying underly mechanisms for diabetic complications and testing reagents for their ability to promote delayed corneal wound healing by hyperglycemia16,17. The results shown in Figure 3 indicate that the antimicrobial peptide LL-37 partially mitigated the impaired wound healing caused by high glucose (HG) in an EGFR- and PI3K-dependent manner, and restored EGFR signaling disrupted by HG in cultured porcine corneas. High glucose conditions reduced LL-37 expression in cultured human corneal epithelial cells (HCECs). Thus, LL-37 acts as a tonic factor that promotes EGFR signaling and enhances epithelial wound healing under both normal and high glucose conditions. Given its antimicrobial and regenerative properties, LL-37 may be a promising therapeutic option for diabetic keratopathy. Other factors such as microRNAs, antioxidants, ER stress inhibitors, and necroptosis inhibitors might also be tested in this system for their ability to overcome the negative effects of hyperglycemia on corneal health and for providing information for establishing a network of pathways and biological processes involved in corneal wound healing and their defects in diabetic corneas.

There is renewed interest in developing medical countermeasures to reduce mortality and serious morbidity during and after major public health emergencies involving the deliberate or accidental large-scale release of highly toxic chemicals (HTCs), such as vesicants28,29,33. This ex vivo pig corneal culture model with filter papers wetted with nitrogen mustard as a means of ocular exposure nitrogen mustard was demonstrated to cause corneal destruction in a dosage and exposure-time-dependent manner. DNA alkylation and cross-linking were the major causes of cell damage (Yu et al., unpublished). Pig organ culture is an ideal and complementary model to animal models for this line of studies of chemicals used as weapons, as they cause several ocular damages, even blindness, in humans and test animals.

Disclosures

The authors have nothing to disclose.

Acknowledgements

We thank Drs. Keping Xu (M.D. and O.D.) and Jia Yin (M.D. and Ph.D.) for their contributions to the development of bovine and porcine corneal organ culture and Ray Guo and Andy Wu of Troy High School for the artwork of Figure 1. Dr. Yu's lab research was funded by NIH grants (R01 EY010869, R01EY035785, P30 EY04068) and by Research to Prevent Blindness at Kresge Eye Institute.

Materials

1.7 mL tubes Axygen AXYMCT175SP
Agarose  Thermo Scientific R0491
Bromfenac (Prolensa) 0.09% 
Camera Canon PowerShot A620
Cell Culture Dish Corning 430165
D-glucose  Sigma 50-99-7
Dissecting microscope  Zeiss Stemi 2000c
Forceps FisherScientific 10-316A
Hemostat FisherScientific 13-812-14
Ketorolac (Acular) 0.45% Kresge Clinic
Kimwipes Kimtech 34155
LL-37 Tocris 5213/1
Minimum essential medium (MEM)  Gibco A1048901
Nepafenac (Ilevro) 0.1% 
Penicillin-streptomycin  Gibco 15070063
Phosphate buffered saline Sigma P4417
Pig eyes  Bernthal Packing Inc.
Pipet tips VWR 76322-164
Porcine corneas Bernthal Packing , Inc. Frankenmuth, MI 
Povidone-Iodine  Betadine
Q-Tips cotton swabs Q-Tips
Razor blade Electron Microscopy Sciences 72002-01
Razor blade holder  Stotz
Scalpel Bard-Parker 377112
Scalpel Handle Bard-Parker #3
Scissors FisherScientific 08-951-20
Silicon mold
Tissue culter enclosure Labconco 5100000
Trephine Acu.Punch 3813775
Water bath  VWR 1235

References

  1. Post, A., et al. Elucidating the role of graft compliance mismatch on intimal hyperplasia using an ex vivo organ culture model. Acta Biomater. 8, 84-94 (2019).
  2. Verma, A., Verma, M., Singh, A. Animal tissue culture principles and applications. Animal Biotechnol. , 269-293 (2020).
  3. Kunzmann, B. C., et al. Establishment of a porcine corneal endothelial organ culture model for research purposes. Cell Tissue Bank. 19 (3), 269-276 (2018).
  4. Ljubimov, A. V., et al. Human corneal epithelial basement membrane and integrin alterations in diabetes and diabetic retinopathy. J Histochem Cytochem. 46 (9), 1033-1041 (1998).
  5. Shah, R., et al. Reversal of dual epigenetic repression of non-canonical Wnt-5a normalizes diabetic corneal epithelial wound healing and stem cells. Diabetologia. 66 (10), 1943-1958 (2023).
  6. Poe, A. J., et al. Regulatory role of miR-146a in corneal epithelial wound healing via its inflammatory targets in human diabetic cornea. Ocul Surf. 25, 92-100 (2022).
  7. Xu, K. P., Li, X. F., Yu, F. S. Corneal organ culture model for assessing epithelial responses to surfactants. Toxicol Sci. 58 (2), 306-314 (2000).
  8. Wilson, S. L., Ahearne, M., Hopkinson, A. An overview of current techniques for ocular toxicity testing. Toxicology. 327, 32-46 (2015).
  9. Rose, J. S., et al. An experimental study to test the efficacy of mesenchymal stem cells in reducing corneal scarring in an ex-vivo organ culture model. Exp Eye Res. 190, 107891 (2020).
  10. Xu, K. P., Li, Y., Ljubimov, A. V., Yu, F. S. High glucose suppresses epidermal growth factor receptor/phosphatidylinositol 3-kinase/Akt signaling pathway and attenuates corneal epithelial wound healing. Diabetes. 58 (5), 1077-1085 (2009).
  11. Seyed-Safi, A. G., Daniels, J. T. A validated porcine corneal organ culture model to study the limbal response to corneal epithelial injury. Exp Eye Res. 197, 108063 (2020).
  12. Peng, M., et al. An ex vivo model of human corneal rim perfusion organ culture. Exp Eye Res. 214, 108891 (2022).
  13. Elsheikh, A., Alhasso, D., Rama, P. Biomechanical properties of human and porcine corneas. Exp Eye Res. 86 (5), 783-790 (2008).
  14. Zeng, Y., Yang, J., Huang, K., Lee, Z., Lee, X. A comparison of biomechanical properties between human and porcine cornea. J Biomech. 34 (4), 533-537 (2001).
  15. Yoon, C. H., Choi, H. J., Kim, M. K. Corneal xenotransplantation: Where are we standing. Prog Retin Eye Res. 80, 100876 (2021).
  16. Xu, K. P., Ding, Y., Ling, J., Dong, Z., Yu, F. S. Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells. Invest Ophthalmol Vis Sci. 45 (3), 813-820 (2004).
  17. Xu, K. P., Yin, J., Yu, F. S. Lysophosphatidic acid promoting corneal epithelial wound healing by transactivation of epidermal growth factor receptor. Invest Ophthalmol Vis Sci. 48 (2), 636-643 (2007).
  18. Yan, C., et al. Targeting Imbalance between IL-1beta and IL-1 receptor antagonist ameliorates delayed epithelium wound healing in diabetic mouse corneas. Am J Pathol. 186 (6), 1466-1480 (2016).
  19. Gao, N., Yu, F. S. Lack of elevated expression of TGFbeta3 contributes to the delay of epithelial wound healing in diabetic corneas. Invest Ophthalmol Vis Sci. 65 (3), 35 (2024).
  20. Richardson, K. C., Jarett, L., Finke, E. H. Embedding in epoxy resins for ultrathin sectioning in electron microscopy. Stain Technol. 35, 313-323 (1960).
  21. Xu, K., McDermott, M., Villanueva, L., Schiffman, R. M., Hollander, D. A. Ex vivo corneal epithelial wound healing following exposure to ophthalmic nonsteroidal anti-inflammatory drugs. Clinical Ophthalmol. 5, 269-274 (2011).
  22. Goldstein, M. H., Silva, F. Q., Blender, N., Tran, T., Vantipalli, S. Ocular benzalkonium chloride exposure: problems and solutions. Eye (Lond). 36 (2), 361-368 (2022).
  23. Xu, K., Yu, F. S. Impaired epithelial wound healing and EGFR signaling pathways in the corneas of diabetic rats. Invest Ophthalmol Vis Sci. 52, 3301-3308 (2011).
  24. Gao, N., Yin, J., Yoon, G. S., Mi, Q. S., Yu, F. S. Dendritic cell-epithelium interplay is a determinant factor for corneal epithelial wound repair. Am J Pathol. 179 (5), 2243-2253 (2011).
  25. Yin, J., Yu, F. S. LL-37 via EGFR transactivation to promote high glucose-attenuated epithelial wound healing in organ-cultured corneas. Invest Ophthalmol Vis Sci. 51 (4), 1891-1897 (2010).
  26. Xu, K. P., Li, X. F., Yu, F. S. Corneal organ culture model for assessing epithelial responses to surfactants. Toxicol Sci. 58 (2), 306-314 (2000).
  27. Abhari, S., et al. Anatomic studies of the miniature swine cornea. Anat Rec (Hoboken). 301 (11), 1955-1967 (2018).
  28. Araj, H., Tseng, H., Yeung, D. T. Supporting discovery and development of medical countermeasures for chemical injury to eye and skin. Exp Eye Res. 221, 109156 (2022).
  29. Araj, H., Tumminia, S. J., Yeung, D. T. Ocular surface: Merging challenges and opportunities. Transl Vis Sci Technol. 9 (12), 3 (2020).
  30. Lee, M., Hwang, J. H., Lim, K. M. Alternatives to in vivo draize rabbit eye and skin irritation tests with a focus on 3D reconstructed human cornea-like epithelium and epidermis models. Toxicol Res. 33 (3), 191-203 (2017).
  31. Xu, K., McDermott, M., Villanueva, L., Schiffman, R. M., Hollander, D. A. Ex vivo corneal epithelial wound healing following exposure to ophthalmic nonsteroidal anti-inflammatory drugs. Clin Ophthalmol. 5, 269-274 (2011).
  32. Bettahi, I., et al. Genome-wide transcriptional analysis of differentially expressed genes in diabetic, healing corneal epithelial cells: Hyperglycemia-suppressed TGFbeta3 expression contributes to the delay of epithelial wound healing in diabetic corneas. Diabetes. 63 (2), 715-727 (2014).
  33. Yeung, D. T., Araj, H., Harper, J. R., Platoff, G. E. Considerations in developing medical countermeasures against chemical ocular toxicity. Toxicol Lett. 334, 1-3 (2020).

Play Video

Cite This Article
Gao, N., McDermott, M., Yu, F. Evaluating Therapeutic and Chemical Toxicity Using Organ-Cultured Porcine Corneas and Epithelial Wound Healing. J. Vis. Exp. (215), e67326, doi:10.3791/67326 (2025).

View Video